Noratest Overview
- Status
-
Out of Business
- Employees
-
5
- Latest Deal Type
-
Liquidation
Noratest General Information
Description
Developer of molecular diagnostic test tools intended to detect Alzheimer's disease. The company's tools can discriminate patients with Alzheimer's disease from those suffering from other neurodegenerative diseases, by measuring specific blood biomarkers, enabling the medical industry to detect Alzheimer's disease by just a simple blood test.
Contact Information
Website
www.alzohis.comCorporate Office
- 28 Rue du Faubourg Poissonnière
- 75010 Paris
- France
Corporate Office
- 28 Rue du Faubourg Poissonnière
- 75010 Paris
- France
Noratest Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Bankruptcy: Liquidation | 27-Dec-2022 | Completed | Bankruptcy: Liquidation | |||
| 9. Later Stage VC | 13-Jul-2021 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Grant | 31-Mar-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 01-Jan-2017 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 06-Feb-2016 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jun-2014 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 01-Jan-2012 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Oct-2011 | Completed | Generating Revenue | |||
| 1. Grant | 01-Jan-2011 | $26.5K | Completed | Generating Revenue |
Noratest Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | 106 | $1.190902 | $1123.5 | $1123.5 | 1x | $1123.5 | 0.02% |
Noratest Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Noratest Patents
Noratest Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3824294-A1 | Method of performing differential diagnosis of neurodegenerative diseases in a subject | Inactive | 20-Jul-2018 | ||
| US-20210293831-A1 | Method of performing differential diagnosis of neurodegenerative diseases in a subject | Inactive | 20-Jul-2018 | ||
| WO-2020016456-A1 | Method of performing differential diagnosis of neurodegenerative diseases in a subject | Inactive | 20-Jul-2018 | ||
| US-20210249131-A1 | Method of performing differential diagnosis of neurodegenerative diseases in a subject | Inactive | 06-Jun-2018 | ||
| WO-2019234194-A1 | Method of performing differential diagnosis of neurodegenerative diseases in a subject | Inactive | 06-Jun-2018 | G01N33/6896 |
Noratest Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Noratest FAQs
-
Where is Noratest headquartered?
Noratest is headquartered in Paris, France.
-
What is the size of Noratest?
Noratest has 5 total employees.
-
What industry is Noratest in?
Noratest’s primary industry is Biotechnology.
-
Is Noratest a private or public company?
Noratest is a Private company.
-
What is Noratest’s current revenue?
The current revenue for Noratest is .
-
How much funding has Noratest raised over time?
Noratest has raised $2.75M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
